Microneedle Aptamer-Based Sensors for Continuous, Real-Time Therapeutic Drug Monitoring

The ability to continuously monitor the concentration of specific molecules in the body is a long-sought goal of biomedical research. For this purpose, interstitial fluid (ISF) was proposed as the ideal target biofluid because its composition can rapidly equilibrate with that of systemic blood, allo...

Full description

Saved in:
Bibliographic Details
Published inAnalytical chemistry (Washington) Vol. 94; no. 23; pp. 8335 - 8345
Main Authors Wu, Yao, Tehrani, Farshad, Teymourian, Hazhir, Mack, John, Shaver, Alexander, Reynoso, Maria, Kavner, Jonathan, Huang, Nickey, Furmidge, Allison, Duvvuri, Andrés, Nie, Yuhang, Laffel, Lori M., Patti, Mary-Elizabeth, Dassau, Eyal, Wang, Joseph, Arroyo-Currás, Netzahualcóyotl
Format Journal Article
LanguageEnglish
Published United States American Chemical Society 14.06.2022
Subjects
Online AccessGet full text
ISSN0003-2700
1520-6882
1520-6882
DOI10.1021/acs.analchem.2c00829

Cover

More Information
Summary:The ability to continuously monitor the concentration of specific molecules in the body is a long-sought goal of biomedical research. For this purpose, interstitial fluid (ISF) was proposed as the ideal target biofluid because its composition can rapidly equilibrate with that of systemic blood, allowing the assessment of molecular concentrations that reflect full-body physiology. In the past, continuous monitoring in ISF was enabled by microneedle sensor arrays. Yet, benchmark microneedle sensors can only detect molecules that undergo redox reactions, which limits the ability to sense metabolites, biomarkers, and therapeutics that are not redox-active. To overcome this barrier, here, we expand the scope of these devices by demonstrating the first use of microneedle-supported electrochemical, aptamer-based (E-AB) sensors. This platform achieves molecular recognition based on affinity interactions, vastly expanding the scope of molecules that can be sensed. We report the fabrication of microneedle E-AB sensor arrays and a method to regenerate them for multiple uses. In addition, we demonstrate continuous molecular measurements using these sensors in flow systems in vitro using single and multiplexed microneedle array configurations. Translation of the platform to in vivo measurements is possible as we demonstrate with a first E-AB measurement in the ISF of a rodent. The encouraging results reported in this work should serve as the basis for future translation of microneedle E-AB sensor arrays to biomedical research in preclinical animal models.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
This paper was originally published ASAP on June 2, 2022, with an error in Figure 6G. The corrected version was reposted on June 3, 2022.
ISSN:0003-2700
1520-6882
1520-6882
DOI:10.1021/acs.analchem.2c00829